Apoptosis and regulation of Bax and Bcl-X proteins during human neonatal vascular remodeling

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 4, 2000, Pages 957-963

  Kim, Hyo Soo ^a   Hwang, Kyung Kuk ^a   Seo, Jeong Wook ^a   Kim, So Young ^a   Oh, Byung Hee ^a   Lee, Myoung Mook ^a   Park, Young Bae ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Apoptosis; Bax; Bcl 2; Ductus arteriosus; Umbilical vessels

Indexed keywords

FAS ANTIGEN; PROTEIN BCL X;

ANGIOGENESIS; AORTA ARCH; APOPTOSIS; ARTICLE; ASCENDING AORTA; DUCTUS ARTERIOSUS; GENE EXPRESSION SYSTEM; HEMODYNAMICS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY;

EID: 0034113986     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.4.957     Document Type: Article

References (30)

1. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456-1462.
2. James TN. Normal and abnormal consequences of apoptosis in the human heart: from postnatal morphogenesis to paroxysmal arrhythmias. Circulation. 1994;90:556-573.
3. Cho A, Courtman DW, Langille BL. Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ Res. 1995;76:168-175.
4. McGrath JC, MacLennan SJ, Mann AC, Stuart-Smith K, Whittle MJ. Contraction of human umbilical artery, but not vein, by oxygen. J Physiol. 1986;380:513-519.
5. Noel S, Cassin S. Maturation of contractile response of ductus arteriosus to oxygen and drugs. Am J Physiol. 1976;231:240-243.
6. Haegerstrand A, Hemsen A, Gillis C, Larsson O, Lundberg JM. Endothelin: presence in human umbilical vessels, high levels in fetal blood and potent constrictor effect. Acta Physiol Scand. 1989;137:541-542.
7. Coceani F, Armstrong C, Kelsey L. Endothelin is a potent constrictor of the lamb ductus arteriosus. Can J Physiol Pharmacol. 1989;67:902-904.
8. Kim HS, Aikawa M, Kimura K, Kuro-o M, Nakahara K, Suzuki T, Katoh H, Okamoto E, Yazaki Y, Nagai R. Ductus arteriosus: advanced differentiation of smooth muscle cells demonstrated by myosin heavy chain isoform expression in rabbits. Circulation. 1993;88:1804-1810.
9. Slomp J, Gittenberger-de Groot AC, Glukhova MA, Van Musteren JC, Kockx MM, Schwartz SM, Koteliansky VE. Differentiation, dedifferentiation, and apoptosis of smooth muscle cells during the development of the human ductus arteriosus. Arterioscler Thromb Vasc Biol. 1997;17: 1003-1009.
10. Green DR. Apoptotic pathways: the roads to ruin. Cell. 1998;94: 695-698.
11. Haunstetter A, Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res. 1998;82:1111-1129.
12. Mallat Z, Ohan J, Leseche G, Tedgui A. Colocalization of CPP-32 with apoptotic cells in human atherosclerotic plaques. Circulation. 1997;96: 424-428.
13. Wang HE, Keiser JA. Molecular characterization of rabbit CPP32 and its function in vascular smooth muscle cell apoptosis. Am J Physiol. 1998; 274:H1132-H1140.
14. Kim HS, Lee MM, Oh BH, Song JM, Park SK, Yoo KY, Park YB, Choi YS, Lee YW. Variant angina is not associated with angiotensin 1 converting enzyme gene polymorphism but rather with smoking. Coron Artery Dis. 1999;10:227-233.
15. Didenko VV, Hornsby PJ. Presence of double-strand breaks with single-base 3′ overhangs in cells undergoing apoptosis but not necrosis. J Cell Biol. 1996;135:1369-1376.
16. Geng YJ, Libby P. Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1β-converting enzyme. Am J Pathol. 1995;147:251-266.
17. Han DKM, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol. 1995;147:267-277.
18. Isner JM, Keamey M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 1995;91:2703-2711.
19. Bennett MR, Littlewood TD, Schwartz SM, Weissberg PL. Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaques to p53-mediated apoptosis. Circ Res. 1997;81:591-599.
20. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998;281:1322-1326.
21. MacLellan WR, Schneider MD. Death by design: programmed cell death in cardiovascular biology and disease. Circ Res. 1997;81:137-144.
22. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerated programmed cell death. Cell. 1993;74:609-619.
23. Perlman H, Maillard L, Krasinski K, Walsh K. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation. 1997;95:981-987.
24. Ashikenazi A, Dixit VM. Death receptors: signaling and modulation. Science. 1998;281:1305-1308.
25. Nagata S, Golstein P. The Fas death factor. Science. 1995;267: 1449-1456.
26. Geng YJ, Henderson LE, Levesque EB, Muszynski M, Libby P. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1997;17:2200-2208.
27. Okazawa H, Shimizu J, Kamei M, Imafuku I, Hamada H, Kanazawa I. Bcl-2 inhibits retinoic acid-induced apoptosis during the neural differentiation of embryonal stem cells. J Cell Biol. 1996;132:955-968.
28. Cho A, Mitchell L, Koopmans D, Langille BL. Effects of changes in blood flow rate on cell death and cell proliferation in carotid arteries of immature rabbits. Circ Res. 1997;81:328-337.
29. Jones PL, Crack J, Rabinovitch M. Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha-v beta-3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J Cell Biol. 1997;139:279-293.
30. Baker AH, Zaltsman AB, George SJ, Newby AC. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro: TIMP-3 promotes apoptosis. J Clin Invest. 1998;101:1478-1487.